Australian of the Year Richard Scolyer ‘blown away’ by success of radical new brain cancer treatment
Source: ABC News, April 2024
World-first clinical trials of a groundbreaking treatment for aggressive brain tumours are likely to begin soon following “fantastic" results in the high-profile case of Australian of the Year, Professor Richard Scolyer.
Professor Scolyer, 57, was diagnosed with glioblastoma IDH wild-type in early June last year and became “patient zero" in a pioneering immunotherapy approach that has produced remarkable results: the tumour has not come back after 10 months.
“I’m blown away," Professor Scolyer tells Australian Story. “This is not what I expected. The average time to recurrence for the nasty type of brain cancer I’ve got is six months. So, to be out this far is amazing. Amazing."